HLA-C and cancer: HLA-C instead shows more mutations in the peptide-binding groove (figure 2b), and it is interesting to note that HLA-C is the major inhibitory ligand for killer immunoglobulin-like receptors (KIRs), which might help to explain why viruses and cancers target this haplotype differently.